aceclofenac

A simple, specific, sensitive, precise and stability-indicating reversed phase high performance liquid chromatographic method was developed and validated for the simultaneous determination of thiocolchicoside and aceclofenac, using a RP-18 column and a mobile phase composed of 0.1% trifluoroacetic acid: acetonitrile (45:55). The retention time of thiocolchicoside and aceclofenac were found to be 2.35 and 13.2 min, respectively. Linearity was established for both thiocolchicoside and aceclofenac in the range of 0.08-0.8 and 1-10 µg/ml. Both the drugs were subjected to acid, alkali and neutral hydrolysis, oxidation, dry heat, and photolytic degradation. The degradation studies indicated that both thiocolchicoside and aceclofenac were susceptible to acid, alkaline and neutral hydrolysis. The degradation products of thiocolchicoside and aceclofenac were well resolved from the pure drugs with significant differences in the retention time values. This method can be successfully employed for simultaneous quantitative analysis of thiocolchicoside and aceclofenac in bulk drugs and formulations.

The present manuscript describes sensitive, rapid, accurate, and precise second order derivative spectrophotometry method for the simultaneous determination of tramadol hydrochloride and aceclofenac in combined dosage form. The absorbance values at 225 nm and 215 nm of second derivative spectrum was used for the estimation of tramadol hydrochloride and aceclofenac in combined dosage form, respectively without mutual interference. This method obeyed beer’s law in the concentration range of 5-80μg/ml and 4-28μg/ml for tramadol hydrochloride and aceclofenac respectively. The method was successfully applied to combined dosage form because no interference from the excipients was found. The suitability of this method for the quantitative determination of tramadol hydrochloride and aceclofenac was proved by validation. The proposed method was found to be simple and sensitive for the routine quality control application of tramadol hydrochloride and aceclofenac in combined dosage form. The results of analysis have been validated by recovery studies.

This work investigates the development and evaluation of hydrodynamically balanced systems (HBSs) of aceclofenac as single unit capsule. The various HBS capsules were formulated by physical blending of aceclofenac with carbopol 934, hydroxypropyl methyl cellulose, pectin in different ratios. These HBS capsules were evaluated for weight uniformity, drug content uniformity, in vitro floating behavior and drug release in simulated gastric fluids (pH 1.2). All these formulated HBS capsules containing aceclofenac were floated well over 5 hours with no floating lag time, and also showed sustained in vitro drug release in simulated gastric fluid over 5 hours. The aceclofenac release was found to be more sustaining with the addition of polymer i.e. carbopol 934 and hydroxyl propyl methyl cellulose. The drug release pattern of these aceclofenac HBS capsules (F-1, F-4, F-5 and F-8) were correlated well with first order model where F-6 to F-7 and F-2 toF-3 was correlated well with Higuchi model Korsmeyer-Peppas model with Fickian diffusion mechanism. All the experimental results showed that the aceclofenac HBS capsule successfully sustain the drug release along with improve the oral bioavailability of candidate drug.